Kjems Lise Lund 4
4 · Cyclo Therapeutics, Inc. · Filed Mar 10, 2023
Insider Transaction Report
Form 4
Kjems Lise Lund
Chief Medical Officer
Transactions
- Award
Stock Option (Right to buy)
2023-03-07+55,453→ 55,453 totalExercise: $1.28Exp: 2033-03-07→ Common Stock (55,453 underlying)
Footnotes (1)
- [F1]The option vests over a four year period in equal monthly installments.